Also...you guys forgot to mention the company released the announcement with the heading in FULL CAPITAL LETTERS so thats gotta mean it should fly higher?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%